Skip to main content

Cerus Corp

CERS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001020214

In the last 90 days, Cerus Corp insiders filed 0 open-market purchases and 6 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $437.9M in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Cerus Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
4 insiders, $737.5K in total
Insiders trading
4
Net value
−$737.5K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Cerus Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Cerus Corp
NameTitleLast reported holdingLast filingFilings, past year
Menard ChrystalChief Legal Officer936,657Aug 17, 20267
Jayaraman Vivek KChief Executive Officer2,232,211Jul 20, 20267
Green Kevin DennisChief Financial Officer1,062,188Jul 2, 20265
Greenman William MarinerPresident and CEO5,053,036Jul 2, 20264
Bjerkholt EricDirector261,679Jun 11, 20262
Nachtsheim Jami KDirector268,362Jun 2, 20261
Witney FrankDirector340,059Jun 2, 20261
Lucena AnnDirector232,284Jun 2, 20261
Shan HuaDirector192,386Jun 2, 20261
Gregory Dean A.Director146,725Jun 2, 20261
Benjamin Richard JChief Medical Officer777,361Mar 16, 20263
Swisher Daniel N JRDirector207,045Jun 4, 20250
Moore Timothy L.Director205,073Jun 4, 20250
Schulze GailDirector163,420Jun 6, 20240
Corash Laurence MChief Scientific Officer2,339,740Mar 14, 20240
Moore CarolSVP Reg. & Quality490,623Mar 14, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 5, 2021 (view filing)Aug 41 daySwisher Daniel N JRDirectorSSale−12.9K$6.25−$80.5K−12.1%93.4K after
Nov 5, 2021 (view filing)Nov 32 daysBenjamin Richard JChief Medical OfficerSSale−165.0K$7.68−$1.27M−68.5%76.0K after3 lots
Nov 5, 2021 (view filing)Nov 32 daysGreen Kevin DennisChief Financial OfficerSSale−95.7K$7.00−$670.2K−38.5%153.0K after2 lots
Nov 5, 2021 (view filing)Nov 32 daysMenard ChrystalChief Legal OfficerSSale−40.0K$7.70−$308.0K−37.4%67.0K after
Nov 9, 2021 (view filing)Nov 54 daysMoore CarolSVP Reg. & QualitySSale−110.0K$7.94−$873.4K−37.8%181.3K after
Nov 9, 2021 (view filing)Nov 9Same daySchulze GailDirectorSSale−25.0K$7.54−$188.5K−47.1%28.1K after
Jan 5, 2022 (view filing)Jan 32 daysMoore CarolSVP Reg. & QualitySSale−19.1K$7.00−$133.4K−9.5%181.3K after
Mar 1, 2022 (view filing)Feb 254 daysGreenman William MarinerPresident and CEOSSale−308.3K$5.70−$1.76M−16.2%1.59M after2 lots
Mar 15, 2022 (view filing)Mar 141 dayBenjamin Richard JChief Medical OfficerSSale−30.3K$5.04−$152.7K−14.2%182.7K after3 lots
Mar 15, 2022 (view filing)Mar 141 dayGreen Kevin DennisChief Financial OfficerSSale−32.1K$5.04−$161.8K−10.3%280.3K after3 lots
Mar 15, 2022 (view filing)Mar 141 dayCorash Laurence MChief Scientific OfficerSSale−30.3K$5.04−$152.7K−1.4%2.13M after3 lots
Mar 15, 2022 (view filing)Mar 141 dayJayaraman Vivek KChief Operating OfficerSSale−41.7K$5.04−$210.3K−10.2%369.4K after3 lots
Mar 15, 2022 (view filing)Mar 141 dayGreenman William MarinerPresident and CEOSSale−165.0K$5.04−$831.7K−7.7%1.97M after3 lots
Mar 16, 2022 (view filing)Mar 142 daysMenard ChrystalChief Legal OfficerSSale−30.3K$5.04−$152.7K−14.8%174.9K after3 lots
Mar 16, 2022 (view filing)Mar 142 daysMoore CarolSVP Reg. & QualitySSale−28.5K$5.04−$143.7K−9.3%279.3K after3 lots
May 12, 2022 (view filing)May 102 daysGreen Kevin DennisChief Financial OfficerSSale−57.3K$4.98−$285.5K−20.5%223.0K after
Aug 11, 2022 (view filing)Aug 92 daysBenjamin Richard JChief Medical OfficerSSale−10.0K$5.12−$51.2K−5.5%172.7K after
Aug 17, 2022 (view filing)Aug 152 daysMenard ChrystalChief Legal OfficerSSale−10.0K$5.18−$51.8K−5.7%164.9K after
Nov 14, 2022 (view filing)Nov 104 daysSwisher Daniel N JRDirectorSSale−12.5K$3.91−$48.9K−9.9%113.8K after
Mar 14, 2023 (view filing)Mar 131 dayBenjamin Richard JChief Medical OfficerSSale−25.4K$2.79−$70.8K−6.8%347.4K after3 lots
Mar 14, 2023 (view filing)Mar 131 dayCorash Laurence MChief Scientific OfficerSSale−15.3K$2.80−$43.0K−0.7%2.26M after2 lots
Mar 14, 2023 (view filing)Mar 131 dayGreen Kevin DennisChief Financial OfficerSSale−17.2K$2.80−$48.1K−3.8%436.0K after2 lots
Mar 14, 2023 (view filing)Mar 131 dayGreenman William MarinerPresident and CEOSSale−60.5K$2.80−$169.3K−2.2%2.66M after2 lots
Mar 14, 2023 (view filing)Mar 131 dayMenard ChrystalChief Legal OfficerSSale−15.5K$2.80−$43.3K−4.2%349.5K after2 lots
Mar 14, 2023 (view filing)Mar 131 dayJayaraman Vivek KChief Operating OfficerSSale−25.4K$2.80−$71.0K−3.7%658.1K after2 lots
Mar 14, 2023 (view filing)Mar 131 dayMoore CarolSVP Reg. & QualitySSale−13.1K$2.80−$36.6K−3.0%415.9K after2 lots
May 23, 2023 (view filing)May 23Same dayBjerkholt EricDirectorPPurchase+5.00K$2.00+$10.0K+6.5%82.1K after
May 24, 2023 (view filing)May 24Same daySchulze GailDirectorPPurchase+9.85K$2.03+$20.0K+13.4%83.4K after
May 30, 2023 (view filing)May 264 daysSwisher Daniel N JRDirectorPPurchase+5.00K$1.91+$9.55K+4.4%118.8K after
Aug 23, 2023 (view filing)Aug 212 daysBjerkholt EricDirectorPPurchase+10.0K$1.72+$17.2K+8.2%132.1K after
Aug 23, 2023 (view filing)Aug 221 dayLucena AnnDirectorPPurchase+7.50K$1.69+$12.7K+11.6%72.3K after
Dec 13, 2023 (view filing)Dec 13Same dayBjerkholt EricDirectorPPurchase+10.0K$1.62+$16.2K+7.6%142.1K after
Mar 12, 2024 (view filing)Mar 84 daysBenjamin Richard JChief Medical OfficerSSale−29.4K$2.40−$70.5K−5.8%478.1K after
Mar 14, 2024 (view filing)Mar 13-141 dayBenjamin Richard JChief Medical OfficerSSale−35.1K$2.01−$70.7K−7.1%459.6K after2 lots
Mar 14, 2024 (view filing)Mar 13-141 dayCorash Laurence MChief Scientific OfficerSSale−28.4K$2.01−$57.3K−1.2%2.34M after2 lots
Mar 14, 2024 (view filing)Mar 13-141 dayGreenman William MarinerPresident and CEOSSale−125.9K$2.04−$256.9K−3.8%3.18M after2 lots
Mar 14, 2024 (view filing)Mar 13-141 dayJayaraman Vivek KChief Operating OfficerSSale−53.0K$2.01−$106.9K−5.7%878.7K after2 lots
Mar 14, 2024 (view filing)Mar 13-141 dayMenard ChrystalChief Legal OfficerSSale−35.3K$2.01−$71.1K−6.7%490.9K after2 lots
Mar 14, 2024 (view filing)Mar 131 dayMoore CarolSVP Reg. & QualitySSale−20.6K$2.01−$41.5K−4.0%490.6K after2 lots
Mar 14, 2024 (view filing)Mar 13-141 dayGreen Kevin DennisChief Financial OfficerSSale−42.6K$1.99−$84.9K−6.4%618.8K after2 lots
May 9, 2024 (view filing)May 9Same daySwisher Daniel N JRDirectorPPurchase+2.50K$1.88+$4.70K+2.4%107.0K after
May 10, 2024 (view filing)May 91 dayWitney FrankDirectorPPurchase+20.0K$1.89+$37.8K+12.5%180.1K after
May 13, 2024 (view filing)May 103 daysNachtsheim Jami KDirectorPPurchase+2.00K$1.79+$3.58K+1.9%108.4K after
May 14, 2024 (view filing)May 131 dayShan HuaDirectorPPurchase+2.50K$1.99+$4.97K+8.4%32.4K after
Aug 7, 2024 (view filing)Aug 25 daysLateBenjamin Richard JChief Medical OfficerSSale−21.6K$2.50−$54.0K−4.7%438.0K after10b5-1
Aug 19, 2024 (view filing)Aug 154 daysMenard ChrystalChief Legal OfficerSSale−16.7K$2.07−$34.5K−3.4%474.2K after10b5-1
Sep 5, 2024 (view filing)Sep 3-42 daysGreen Kevin DennisChief Financial OfficerSSale−82.7K$2.16−$178.6K−13.4%536.1K after2 lots10b5-1
Dec 16, 2024 (view filing)Dec 16Same dayMenard ChrystalChief Legal OfficerSSale−16.7K$1.71−$28.5K−3.5%457.6K after10b5-1
Dec 16, 2024 (view filing)Dec 124 daysBjerkholt EricDirectorSSale−20.0K$1.79−$35.8K−11.0%162.1K after
Jan 2, 2025 (view filing)Dec 13, 202420 daysLateGregory Dean A.DirectorPPurchase+1.73K$1.70+$2.93K+2.9%61.7K after10b5-1